Search

everythinglearnresearchcommunity

for

Search:↓

Blocking YAP/TAZ could be a new way to treat skin cancer.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

The inhibitor affects androgen metabolism but not ovarian function.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.